TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Randomized Study of Rivaroxaban vs Placebo on Disease Progression and Symptoms Resolution in High-Risk Adults With Mild Coronavirus Disease 2019.

Jintanat Ananworanich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.